Michelle Lowery focuses her practice on complex antitrust litigation, transactional and counseling matters and is a member of the firm’s antitrust and competition practice, which is designated “Global Elite” as one of the top 25 competition practices in the world by Global Competition Review. Michelle has been recognized by the Legal 500 US, Super Lawyers and Benchmark Litigation as excelling in antitrust work. Michelle has a decade of experience in achieving exceptional results for her clients in class action conspiracy, monopolization and exclusive dealing cases. She has significant expertise in the manufacturing and health care/life sciences sectors for both litigation and transactional matters. She has guided many healthcare companies through transformational transactions, while avoiding or resolving antitrust regulators’ inquiries. Michelle also regularly advises clients on a variety of complex distribution chain matters. Michelle works out of both the Los Angeles and Chicago offices.
86
California Senate Bill (SB) 977, if passed, would broaden the type of healthcare transactions that require California Attorney General (AG) review and approval. SB 977 would require that a healthcare system, private equity group or hedge fund provide written notice to, and obtain the written (...)
